Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 19.73 is 80% above its 5-year average of 10.96, near the high end of its 5-year range (3.72–24.23).
As of the fiscal period ended Tuesday, June 30, 2026. 55.81% above its 12-month average of 12.66.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 19.73.
QUICK RATIO (ACID-TEST)
19.73
QUICK RATIO (ACID-TEST) AVG TTM
12.66
QUICK RATIO (ACID-TEST) AVG 3Y
9.41
QUICK RATIO (ACID-TEST) AVG 5Y
10.96
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+55.81%
CURRENT VS 3Y AVG
+109.68%
CURRENT VS 5Y AVG
+80.05%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 608 covered companies
CURRENT VS SECTOR MEDIAN
+559.90%
vs the sector median at left
Damora Therapeutics, Inc.
Market Cap
$1.13B
Quick Ratio (Acid-Test)
19.73
TTM Avg
12.66
3Y Avg
9.41
5Y Avg
10.96
Market Cap
$1.13B
Quick Ratio (Acid-Test)
33.10
TTM Avg
10.19
3Y Avg
10.19
5Y Avg
10.19
Market Cap
$1.11B
Quick Ratio (Acid-Test)
2.08
TTM Avg
2.01
3Y Avg
3.15
5Y Avg
3.64
Market Cap
$1.11B
Quick Ratio (Acid-Test)
1.71
TTM Avg
2.54
3Y Avg
2.42
5Y Avg
2.25
Market Cap
$1.16B
Quick Ratio (Acid-Test)
1.38
TTM Avg
3.96
3Y Avg
6.78
5Y Avg
9.79
Market Cap
$1.09B
Quick Ratio (Acid-Test)
11.59
TTM Avg
21.25
3Y Avg
14.51
5Y Avg
14.51
Market Cap
$1.17B
Quick Ratio (Acid-Test)
10.42
TTM Avg
4.62
3Y Avg
5.77
5Y Avg
6.99
Market Cap
$1.09B
Quick Ratio (Acid-Test)
8.13
TTM Avg
7.23
3Y Avg
6.69
5Y Avg
8.24
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.13B | 19.73 | 12.66 | 9.41 | 10.96 |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | 33.10 | 10.19 | 10.19 | 10.19 |
| Kardigan, Inc. (KARD)vs › | $1.15B | 8.72 | 9.20 | 9.20 | 9.20 |
| Harrow Health, Inc. (HROW)vs › | $1.11B | 2.08 | 2.01 | 3.15 | 3.64 |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.11B | 1.71 | 2.54 | 2.42 | 2.25 |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.16B | 1.38 | 3.96 | 6.78 | 9.79 |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | 11.59 | 21.25 | 14.51 | 14.51 |
| Nektar Therapeutics (NKTR)vs › | $1.17B | 10.42 | 4.62 | 5.77 | 6.99 |
| IRadimed Corporation (IRMD)vs › | $1.09B | 8.13 | 7.23 | 6.69 | 8.24 |
| MannKind Corporation (MNKD)vs › | $1.19B | 1.41 | 2.22 | 2.73 | 2.72 |
Quick Ratio
19.73
Excludes inventory
Current Ratio
19.73
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 19.73 |
| 2026-03-31 | 22.48 |
| 2025-12-31 | 12.98 |
| 2025-09-30 | 3.73 |
| 2025-06-30 | 4.39 |
| 2025-03-31 | 8.64 |
| 2024-12-31 | 14.07 |
| 2024-09-30 | 8.68 |
| 2024-06-30 | 6.79 |
| 2024-03-31 | 7.07 |
| 2023-12-31 | 6.31 |
| 2023-09-30 | 3.75 |
| 2023-06-30 | 3.72 |
| 2023-03-31 | 4.06 |
| 2022-12-31 | 5.75 |
| 2022-09-30 | 8.04 |
| 2022-06-30 | 10.98 |
| 2022-03-31 | 13.45 |
| 2021-12-31 | 24.23 |
| 2021-09-30 | 18.63 |
| 2021-06-30 | 22.65 |
| 2021-03-31 | 21.10 |
| 2020-12-31 | 30.42 |
| 2020-09-30 | 11.53 |
| 2020-03-31 | 0.00 |
| 2019-09-30 | 0.00 |
